INS and type 2 diabetes mellitus: In combination, the data on calcium affinity, release modes, and granule size are consistent with the presence of two distinct subpopulations of insulin granules: larger fast releasing granules that are susceptible to palmitate T2D-mimicking treatment and smaller slow releasing granules that are susceptible to cytokine T1D-mimicking treatment.